KRISTIN GARCIA-MILLER: Open Payments
NPI 1770966335 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 69 payments from 16 companies in 2025. Trend: 2023 $1,394 · 2024 $1,701 · 2025 $1,451
Food & beverage: $1,451
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $206 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $184 |
| Esperion Therapeutics, Inc. | 10 | $164 |
| Amgen Inc. | 11 | $135 |
| CVRx, Inc. | 4 | $115 |
| SCPHARMACEUTICALS INC. | 6 | $114 |
| PFIZER INC. | 5 | $108 |
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| Novo Nordisk Inc | 2 | $51 |
Products named: Kerendia, AVEIR, NEXLETOL, REPATHA, Barostim Neo System, FUROSCIX, LEQVIO, ELIQUIS.
Industry payments across FL — which companies pay providers there.
